Dr. Olga Aroniadis Will Serve as Director of the Master's Program in Epidemiology and Clinical Research

The Department of Medicine is thrilled to announce that our esteemed faculty member, Olga C. Aroniadis, MD, MSc, FACG, Division of Gastroenterology and Hepatology,  has been selected to serve as Director of the Master’s Program in Epidemiology and Clinical Research at Stony Brook University. 

Dr. Aroniadis is currently Associate Professor of Clinical Medicine in the Renaissance School of Medicine, Director of Clinical Research and Director of the Women's Center for Gastroenterological Disease and Disorders at Stony Brook Medicine.

Dr. Olga Aroniadis completed her undergraduate education at Tufts University and graduated summa cum laude. She obtained her medical degree at Albert Einstein College of Medicine and graduated with a Research Distinction in Gastroenterology. Dr. Aroniadis completed her residency training in Internal Medicine at Montefiore Medical Center where she was selected to serve an additional year as a chief resident. She then remained at Montefiore Medical Center for her fellowship in Gastroenterology.

To further her training in clinical research, she also obtained a Master's Degree of Clinical Research Methods at Albert Einstein College of Medicine. Dr. Aroniadis was a faculty member at Montefiore Medical Center from 2015-2019 where she received the Department of Medicine Rising Star Award. Dr. Aroniadis joined the faculty at Stony Brook University in 2019 as Associate Professor of Clinical Medicine and as the GI Division’s Director of Clinical Research.

Dr. Aroniadis' clinical practice is largely centered around functional bowel disorders and gastrointestinal health as it relates to women. Her research interests include studying the effects microbial therapeutics on gastrointestinal diseases, both irritable bowel syndrome and C. difficile infection. In addition to her work on the role of fecal microbiota transplantation for recurrent and severe/complicated C. difficile infection, Dr. Aroniadis completed a clinical trial to assess the role of fecal microbiota transplantation for the treatment of diarrhea-predominant irritable bowel syndrome. This work was supported by a NIH-funded KL2 career development award from Montefiore/Einstein and was presented at the Distinguished Plenary Session at Digestive Diseases Week in 2018, for which Dr. Aroniadis received recognition for Scientific Accomplishment as an Early Career Investigator.

Additionally, Dr. Aroniadis serves on the research committee of the American College of Gastroenterology (ACG). She is also the Course Director for the biannual ACG Imaging and Pathology Course. Dr. Aroniadis is a practicing clinician and educator in the Department of Medicine. As a clinician and educator, she strives to deliver exceptional patient care to patients with a variety of gastrointestinal disease and is dedicated to teaching and mentoring medical students, residents and fellows.

We congratulate Dr. Aroniadis on this well-earned achievement and honor, and we look forward to seeing what she’ll achieve as she collaborates with the leadership of the Program in Public Health, and strives toward growing this important program.

Olga C. Aroniadis, MD, MSc, FACG